Continued Investigation of Acadia Healthcare by Kahn Swick & Foti, LLC Raises Concerns

Kahn Swick & Foti, LLC's Ongoing Investigation into Acadia Healthcare

Acadia Healthcare Company, Inc., traded on NASDAQ under the ticker symbol ACHC, is currently facing scrutiny due to investigations led by Kahn Swick & Foti, LLC (KSF). This investigation is helmed by Charles C. Foti, Jr., a former Attorney General of Louisiana, now a managing partner at KSF. The firm is looking into various allegations related to the company's executives and board members concerning their potential breaches of fiduciary duty to shareholders and compliance with both state and federal laws.

The inquiry intensified after Acadia disclosed receiving a voluntary information request from the U.S. Attorney's Office for the Southern District of New York and a grand jury subpoena from the District Court for the Western District of Missouri. These legal inquiries relate specifically to the company’s admissions, length of stay, and billing practices—significant areas of concern that have emerged in light of previous operational disclosures.

On September 27, 2024, Acadia issued a statement outlining these legal challenges, leading to further complications for the company. Just a month later, on October 30, it revised its financial projections for the year. Acadia's full-year revenue outlook is now expected to be between $3.15 to $3.165 billion, a significant dip prompted by disappointing patient growth statistics that reported only a 3% increase in patient days during October.

These issues aren't merely procedural; they stem from a lingering concern surrounding investor trust. The company has become embroiled in a securities class action lawsuit, accused of withholding crucial information that would have influenced investors' decisions. The recent ruling by the presiding court denied Acadia’s attempts to dismiss the lawsuit, thus allowing the case to progress.

In light of these developments, Kahn Swick & Foti, LLC is focusing their investigation on whether Acadia’s officers and board members acted in the best interests of the company’s shareholders or if they failed in their obligations. KSF is reaching out to potential whistleblowers and stakeholders—particularly long-term shareholders—who may have insights or experiences pertinent to these allegations. Shareholders are encouraged to come forward with any relevant information that could support the investigation at no cost or obligation.

To support their inquiries, KSF is providing various contact options for individuals with tips or insights. Interested parties can reach out via KSF's hotline at 1-833-538-3608 or send an email to Managing Partner Lewis Kahn at [email protected] Additionally, more information about the investigation can be found on the KSF website at https://www.ksfcounsel.com/cases/nasdaqgs-achc/

About Kahn Swick & Foti, LLC

Kahn Swick & Foti, LLC stands as one of the nation’s leading boutique law firms specializing in securities litigation. With a reputation bolstered by high-profile cases and settlements, KSF takes pride in representing both institutional and retail investors in their pursuit of legal remedies against corporate malfeasance.

Ranked among the top firms nationwide for settlement achievements, KSF operates across several states, offering its expertise to clients grappling with the fallout from corporate fraud and similar wrongdoing. For those affected by Acadia Healthcare’s recent challenges, KSF may provide not only guidance but also a form of advocacy that addresses their grievances.

For further engagement or if you wish to learn more about Kahn Swick & Foti, please visit their official website https://www.ksfcounsel.com or reach out to their office directly in New Orleans, LA.